Contents

Current Pharmaceutical Design, Volume 7 - Number 13

Preface

, 7(13): ii

Bridget T. HILL and Jacques FAHY


DOI: 10.2174/1381612013397500




Modifications in the upper or Velbenamine Part of the Vinca Alkaloids have Major Implications for Tubulin Interacting Activities

, 7(13): 1181 - 1197

Jacques Fahy


DOI: 10.2174/1381612013397483




Vinflunine, a Second Generation Novel Vinca Alkaloid with a Distinctive Pharmacological Profile, now in Clinical Development and Prospects for Future Mitotic Blockers

, 7(13): 1199 - 1212

Bridget T. Hill


DOI: 10.2174/1381612013397456




Physiochemical Aspects of Tubulin-Interacting Antimitotic Drugs

, 7(13): 1213 - 1228

J. J. Correia and S. Lobert


DOI: 10.2174/1381612013397438




General and Recent Aspects of the Chemistry and Structure Activity Relationships of Taxoids

, 7(13): 1229 - 1249

Francoise Gueritte


DOI: 10.2174/1381612013397429




Preclinical Evaluation of New Taxoids

, 7(13): 1251 - 1257

M. -C. Bissery


DOI: 10.2174/1381612013397465




Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides

, 7(13): 1259 - 1276

Chuan Shih and Beverly A. Teicher


DOI: 10.2174/1381612013397474




The Epothilones, Eleutherobins, and Related Types of Molecules

, 7(13): 1277 - 1290

Shawn J. Stachel, Kaustav Biswas and Samuel J. Danishefsky


DOI: 10.2174/1381612013397410




Spongistatins as Tubulin Targeting Agents

, 7(13): 1291 - 1296

F. M. Uckun, C. Mao, S. -T. jan, H. Huang, A. O. Vassilev, C. S. Navara and R. K. Narla


DOI: 10.2174/1381612013397492




Epilogue

, 7(13): 1297 - 1301

Jacques Fahy and Bridget T. Hill


DOI: 10.2174/1381612013397447




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science